Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Public Health & Economic Impact Study
    • Stories of Discovery
    • Chen Lecture Videos
    • NIH Patents and Active Patent Commercialization Licenses
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Patent Applications

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NCI

Gamma Beta-Mediated Recombination At The Replication Fork With Synthetic Single Strand DNA Oliganucleotides. Generation Of Mismatched DNA Strands: A Model.

  • Read more about Gamma Beta-Mediated Recombination At The Replication Fork With Synthetic Single Strand DNA Oliganucleotides. Generation Of Mismatched DNA Strands: A Model.
Patent Cooperation Treaty
PCT/US2003/14657
Filed on 2003-05-09

ENCAPSULATED AND NON-ENCAPSULATED NITRIC OXIDE GENERATORS USED AS ANTIMICROBIAL AGENTS

  • Read more about ENCAPSULATED AND NON-ENCAPSULATED NITRIC OXIDE GENERATORS USED AS ANTIMICROBIAL AGENTS
US Application 08/133,601
Filed on 1993-10-07

Immunotherapy Regimens in HIV-Infected Patients

  • Read more about Immunotherapy Regimens in HIV-Infected Patients
Patent Cooperation Treaty
PCT/US2003/013737
Filed on 2003-05-01

RECOMBINANT ADENOVIRAL TARGETING VECTOR

  • Read more about RECOMBINANT ADENOVIRAL TARGETING VECTOR
US Application 10/393,694
Filed on 2003-03-20

Improved Immunogenicity Using a Combination of DNA And Vaccinia Virus Vector Vaccines

  • Read more about Improved Immunogenicity Using a Combination of DNA And Vaccinia Virus Vector Vaccines
Canada
2407303
Filed on 2001-04-30

Human Papilloma Virus Anti-Sense Oligonucleotides

  • Read more about Human Papilloma Virus Anti-Sense Oligonucleotides
European Patent
05009714.6
Filed on 1998-09-03

Expression Vectors Able To Elicit Improved Immune Response and Methods of Using Same

  • Read more about Expression Vectors Able To Elicit Improved Immune Response and Methods of Using Same
US Application 10/415,431
Filed on 2003-04-28

METHODS OF SCREENING AND DIAGNOSTICS USING ATP-BINDING CASSETTE TRANSPORTER

  • Read more about METHODS OF SCREENING AND DIAGNOSTICS USING ATP-BINDING CASSETTE TRANSPORTER
US Patent 7,189,511
Filed on 2003-01-03

METHOD FOR TREATING CANCER IN HUMANS

  • Read more about METHOD FOR TREATING CANCER IN HUMANS
Patent Cooperation Treaty
PCT/US2003/009707
Filed on 2003-03-27

An Epithelial Cell Specific Growth Factor, Keratinocyte Growth Factor (KGF) (as amended)

  • Read more about An Epithelial Cell Specific Growth Factor, Keratinocyte Growth Factor (KGF) (as amended)
US Application 11/346,626
Filed on 2006-02-03

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 1127
  • Page 1128
  • Page 1129
  • Page 1130
  • Page 1131
  • Page 1132
  • Page 1133
  • Page 1134
  • Page 1135
  • …
  • Next page ››
  • Last page Last »
Subscribe to NCI
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health